Neurology Today in 5

De: American Academy of Neurology
  • Sumário

  • Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
    2024
    Exibir mais Exibir menos
Episódios
  • Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
    Sep 19 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.

    Exibir mais Exibir menos
    5 minutos
  • Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
    Sep 5 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.

    Exibir mais Exibir menos
    5 minutos
  • Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
    Aug 15 2024

    In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.

    Exibir mais Exibir menos
    5 minutos
activate_samplebutton_t1

O que os ouvintes dizem sobre Neurology Today in 5

Nota média dos ouvintes. Apenas ouvintes que tiverem escutado o título podem escrever avaliações.

Avaliações - Selecione as abas abaixo para mudar a fonte das avaliações.